| __timestamp | Alkermes plc | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 241751000 |
| Thursday, January 1, 2015 | 4019000 | 322292000 |
| Friday, January 1, 2016 | 2301000 | 344320000 |
| Sunday, January 1, 2017 | 7232000 | 374644000 |
| Monday, January 1, 2018 | 68895000 | 414604000 |
| Tuesday, January 1, 2019 | 52816000 | 466000000 |
| Wednesday, January 1, 2020 | 1946000 | 535000000 |
| Friday, January 1, 2021 | 1020000 | 643000000 |
| Saturday, January 1, 2022 | 393842000 | 833000000 |
| Sunday, January 1, 2023 | 270806000 | 899625000 |
| Monday, January 1, 2024 | 245326000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. has consistently outpaced Alkermes plc in R&D investment. From 2014 to 2023, Ionis increased its R&D spending by approximately 272%, reaching nearly $900 million in 2023. In contrast, Alkermes saw a more modest increase, with a peak in 2022 at around $394 million, before slightly declining in 2023.
This strategic focus on R&D by Ionis underscores its dedication to pioneering new therapies and maintaining a competitive edge. Meanwhile, Alkermes' fluctuating investment suggests a more cautious approach. As the biotech industry continues to evolve, these spending patterns may significantly influence each company's future growth and innovation potential.
R&D Insights: How Jazz Pharmaceuticals plc and Alkermes plc Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Alkermes plc vs Opthea Limited
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Alkermes plc or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and CRISPR Therapeutics AG
Alkermes plc vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Alkermes plc vs ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Alkermes plc vs Agios Pharmaceuticals, Inc.